Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal ropivacaine for pain after day-case diagnostic laparoscopy and hysteroscopy
ACTRN12609000128291Phase 4Completed
- Sponsor
- Dr Natasha Frawley
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Dr Natasha Frawley. Primary endpoint: Amount of postoperative analgesia used. Started Jun 2009; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ACTRN12609000128291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000128291.